The tweet was deleted by the author.
But we saved everything 🙂.
Arvinas has released its financial results for the second quarter of 2026.
The earnings announcement offers investors detailed insight into the company’s recent performance, while potentially shaping expectations for future quarters. More specific figures and forward-looking commentary from Arvinas are likely accessible in the company’s full earnings report. Further details can be found via the company's press release and presentation.
View post on X Loading...
Earlier this year, Arvinas presented early-stage Alzheimer research data on its PROTAC LRRK2 degraders at AAIC26 in London. The company also took part in the AACR D3 conference in Boston to discuss developments in cancer drug discovery. These activities reflect Arvinas’s continued engagement in research and development.